Perry Sternberg, Corium Pharma Solutions CEO
Updated: With new $100M investment, a biotech with two approved drugs spins out its manufacturing business
A biotech has decided to break off a part of its business in a new deal.
The Massachusetts-based biotech Corium, which is centered around developing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
